+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46



Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46



Blood 120(26): 5237-5246



Activated protein C (APC) exerts endothelial cytoprotective actions that require protease-activated receptor 1 (PAR1), whereas thrombin acting via PAR1 causes endothelial disruptive, proinflammatory actions. APC's activities, but not thrombin's, require PAR1 located in caveolae. PAR1 is a biased 7-transmembrane receptor because G proteins mediate thrombin's signaling, whereas β-arrestin 2 mediates APC's signaling. Here we elucidate novel mechanisms for APC's initiation of signaling. Biochemical studies of APC's protease specificity showed that APC cleaved PAR1 sequences at both Arg41 and Arg46. That PAR1 cleavage at Arg46 can occur on cells was supported by APC's cleavage of N-terminal-SEAP-tagged R41Q-PAR1 but not R41Q/R46Q-PAR1 mutants transfected into cells and by anti-PAR1 epitope mapping of APC-treated endothelial cells. A synthetic peptide composing PAR1 residues 47-66, TR47, stimulated protective signaling in endothelial cells as reflected in Akt and glycogen synthase kinase 3β phosphorylation, Ras-related C3 botulinum toxin substrate 1 activation, and barrier stabilization effects. In mice, the TR47 peptide reduced VEGF-induced vascular leakage. These in vitro and in vivo data imply that the novel PAR1 N-terminus beginning at residue Asn47, which is generated by APC cleavage at Arg46, mediates APC's cytoprotective signaling and that this unique APC-generated N-terminal peptide tail is a novel biased agonist for PAR1.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036682685

Download citation: RISBibTeXText

PMID: 23149848

DOI: 10.1182/blood-2012-08-452169


Related references

Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3. Blood 122(5): 807-816, 2013

Protease-Activated Receptor-1 Supports Locomotor Recovery by Biased Agonist Activated Protein C after Contusive Spinal Cord Injury. Plos One 12(1): E0170512, 2017

Proteases display biased agonism at protease-activated receptors: location matters!. Molecular Interventions 9(2): 87-96, 2009

Activated protein C suppresses osteoclast differentiation via endothelial protein C receptor, protease-activated receptor-1, sphingosine 1-phosphate receptor, and apolipoprotein E receptor 2. Thrombosis Research 163: 30-40, 2018

Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1. Blood 101(12): 4797-4801, 2003

Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen-activated protein kinase pathways. Molecular Pharmacology 76(4): 791-801, 2009

Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C. Journal of Investigative Dermatology 125(6): 1279-1285, 2005

Store-operated Ca2+ entry (SOCE) induced by protease-activated receptor-1 mediates STIM1 protein phosphorylation to inhibit SOCE in endothelial cells through AMP-activated protein kinase and p38β mitogen-activated protein kinase. Journal of Biological Chemistry 288(23): 17030-17041, 2013

Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 38(6): 1368-1380, 2018

Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans. Circulation 114(15): 1625-1632, 2006

Biased Signaling by Agonists of Protease Activated Receptor 2. Acs Chemical Biology 12(5): 1217-1226, 2017

Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster. Molecular Medicine 2(3): 349-357, 1996

To be or not to be protease activated receptor-1 in activated protein C-initiated endothelial barrier protection?. Critical Care 11(1): 407; Author Reply 407, 2007

Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1. Journal of Biological Chemistry 282(35): 25493-25500, 2007

Thrombin activates mitogen activated protein kinases through protease activated receptor 1. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 300 7, 2002